Closing the gap "Disparity in Native Hawaiian cardiac care"

Ann Cook1, Coraleen T Grothaus, Carol E Gutierrez

  • 1The Queen's Medical Center– Queen’s Heart, 1301 Punchbowl Street, Honolulu, HI 96813, USA. ancook@queens.org

Insights

A culturally sensitive cardiac care program improved health outcomes for Native Hawaiians. The initiative reduced readmissions and adverse events, enhancing patient satisfaction and closing health disparity gaps.

Area of Science:

  • Cardiovascular Medicine
  • Health Disparities
  • Cultural Competency in Healthcare

Background:

  • Native Hawaiians experience significant health disparities in cardiac care.
  • The Queen's Medical Center identified a need for culturally sensitive interventions to address these gaps.

Purpose of the Study:

  • To examine healthcare processes and outcomes for Native Hawaiians with heart disease.
  • To evaluate the impact of a multidisciplinary, culturally sensitive program on quality of care.

Main Methods:

  • An inpatient program was developed with practitioners knowledgeable in Native Hawaiian culture.
  • Culturally specific educational materials and self-care management tools were provided.
  • Heart failure disease management ensured tailored education and outpatient follow-up plans.

Main Results:

  • All quality indicators for Native Hawaiian cardiac patients showed improvement.
  • Patient satisfaction remained at the 99th percentile.
  • Adverse events post-percutaneous coronary intervention (PCI) and 30-day readmission rates for myocardial infarction and heart failure improved significantly.

Conclusions:

  • Culturally sensitive, patient-centered care enhanced patient recovery and incorporation of cultural preferences.
  • The program led to decreased readmission rates and improved mortality.
  • Patient and family satisfaction were significantly enhanced.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...